Cargando…
New emerging SARS-CoV-2 variants and antiviral agents
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292910/ https://www.ncbi.nlm.nih.gov/pubmed/37390619 http://dx.doi.org/10.1016/j.drup.2023.100986 |
_version_ | 1785062909881090048 |
---|---|
author | Vitiello, A. Zovi, A. Rezza, G. |
author_facet | Vitiello, A. Zovi, A. Rezza, G. |
author_sort | Vitiello, A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10292910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102929102023-06-27 New emerging SARS-CoV-2 variants and antiviral agents Vitiello, A. Zovi, A. Rezza, G. Drug Resist Updat Editorial Elsevier Ltd. 2023-09 2023-06-26 /pmc/articles/PMC10292910/ /pubmed/37390619 http://dx.doi.org/10.1016/j.drup.2023.100986 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Editorial Vitiello, A. Zovi, A. Rezza, G. New emerging SARS-CoV-2 variants and antiviral agents |
title | New emerging SARS-CoV-2 variants and antiviral agents |
title_full | New emerging SARS-CoV-2 variants and antiviral agents |
title_fullStr | New emerging SARS-CoV-2 variants and antiviral agents |
title_full_unstemmed | New emerging SARS-CoV-2 variants and antiviral agents |
title_short | New emerging SARS-CoV-2 variants and antiviral agents |
title_sort | new emerging sars-cov-2 variants and antiviral agents |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292910/ https://www.ncbi.nlm.nih.gov/pubmed/37390619 http://dx.doi.org/10.1016/j.drup.2023.100986 |
work_keys_str_mv | AT vitielloa newemergingsarscov2variantsandantiviralagents AT zovia newemergingsarscov2variantsandantiviralagents AT rezzag newemergingsarscov2variantsandantiviralagents |